Applied Finance Capital Management LLC Purchases 9,075 Shares of Danaher Corporation $DHR

Key Points

• Applied Finance Capital Management LLC increased its holdings in Danaher Corporation by 16.0% in the second quarter, now owning 65,728 shares worth approximately $12.98 million.
• Danaher reported earnings of $1.80 per share for the most recent quarter, surpassing analysts' expectations, with revenue of $5.94 billion, up 3.4% from the previous year.
• The company also announced a quarterly dividend of $0.32 per share, representing an annualized yield of 0.6%, payable on October 31st to shareholders of record as of September 26th.

Applied Finance Capital Management LLC lifted its position in shares of Danaher Corporation (NYSE:DHR - Free Report) by 16.0% in the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 65,728 shares of the conglomerate's stock after buying an additional 9,075 shares during the quarter. Applied Finance Capital Management LLC's holdings in Danaher were worth $12,984,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. GHP Investment Advisors Inc. boosted its holdings in Danaher by 396.0% in the 1st quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate's stock valued at $25,000 after purchasing an additional 99 shares during the period. Sierra Ocean LLC increased its holdings in shares of Danaher by 116.9% during the first quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate's stock worth $29,000 after purchasing an additional 76 shares during the period. Red Tortoise LLC raised its position in shares of Danaher by 175.0% in the second quarter. Red Tortoise LLC now owns 154 shares of the conglomerate's stock valued at $30,000 after buying an additional 98 shares in the last quarter. Smallwood Wealth Investment Management LLC bought a new stake in shares of Danaher in the first quarter valued at approximately $31,000. Finally, Dunhill Financial LLC boosted its stake in shares of Danaher by 68.4% in the first quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate's stock valued at $34,000 after buying an additional 67 shares during the period. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, Director Teri List sold 2,778 shares of the company's stock in a transaction on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total transaction of $586,324.68. Following the completion of the transaction, the director directly owned 20,751 shares in the company, valued at approximately $4,379,706.06. This represents a 11.81% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 11.10% of the company's stock.

Danaher Stock Performance

Danaher stock opened at $210.86 on Friday. The company has a quick ratio of 1.22, a current ratio of 1.62 and a debt-to-equity ratio of 0.32. The stock has a market cap of $150.99 billion, a PE ratio of 44.86, a P/E/G ratio of 2.94 and a beta of 0.77. Danaher Corporation has a 12-month low of $171.00 and a 12-month high of $279.41. The business's 50-day moving average price is $201.43 and its two-hundred day moving average price is $197.23.

Danaher (NYSE:DHR - Get Free Report) last posted its quarterly earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, beating analysts' consensus estimates of $1.64 by $0.16. The company had revenue of $5.94 billion for the quarter, compared to the consensus estimate of $5.83 billion. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The firm's quarterly revenue was up 3.4% compared to the same quarter last year. During the same period last year, the company posted $1.72 EPS. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, analysts expect that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be paid a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date of this dividend is Friday, September 26th. Danaher's payout ratio is presently 27.23%.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on the company. Rothschild Redb lowered Danaher from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, October 8th. Wall Street Zen upgraded Danaher from a "hold" rating to a "buy" rating in a research report on Friday, June 27th. Redburn Partners set a $220.00 price target on Danaher in a research note on Wednesday, October 8th. Robert W. Baird increased their price objective on shares of Danaher from $225.00 to $226.00 and gave the stock an "outperform" rating in a research note on Friday, July 18th. Finally, Guggenheim restated a "buy" rating and issued a $250.00 target price on shares of Danaher in a research report on Wednesday, July 23rd. Seventeen research analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $244.60.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.